Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Abstract The use of patient‐reported outcomes (PROMs) of quality of life (QOL) is common in cachexia trials. Patients' self‐report on health, functioning, wellbeing, and perceptions of care, represent important measures of efficacy. This review describes the frequency, variety, and reporting of...
Saved in:
Main Authors: | Marianne J. Hjermstad (Author), Gunnhild Jakobsen (Author), Jann Arends (Author), Trude R. Balstad (Author), Leo R. Brown (Author), Asta Bye (Author), Andrew J.S. Coats (Author), Olav F. Dajani (Author), Ross D. Dolan (Author), Marie T. Fallon (Author), Christine Greil (Author), Alexandra Grzyb (Author), Stein Kaasa (Author), Lisa H. Koteng (Author), Anne M. May (Author), James McDonald (Author), Inger Ottestad (Author), Iain Philips (Author), Eric J. Roeland (Author), Judith Sayers (Author), Melanie R. Simpson (Author), Richard J.E. Skipworth (Author), Tora S. Solheim (Author), Mariana S. Sousa (Author), Ola M. Vagnildhaug (Author), Barry J.A. Laird (Author), the Cancer Cachexia Endpoints Working Group (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
by: Ola Magne Vagnildhaug, et al.
Published: (2024) -
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024) -
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
by: Leo R. Brown, et al.
Published: (2024) -
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
by: James McDonald, et al.
Published: (2023) -
Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
by: Tateaki Naito
Published: (2019)